FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, specifically to producing a polypeptide forming a chimeric antigen receptor (hereinafter – CAR) containing antigen-binding domain, super-spiral spacer domain, transmembrane domain, and endo-domain; it can be used in medicine.
EFFECT: multimeric CAR formed by combining a set of polypeptides forming CAR by association of their super-spiral domains can be used for the effective immunotherapy of cancer.
37 cl, 16 dwg, 5 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SIGNAL SYSTEM | 2015 |
|
RU2731638C2 |
| CELL | 2014 |
|
RU2717984C2 |
| CELL | 2014 |
|
RU2732236C2 |
| CELL | 2015 |
|
RU2768019C2 |
| CHIMERIC ANTIGENE RECEPTOR | 2019 |
|
RU2810092C2 |
| CHIMERIC PROTEIN | 2016 |
|
RU2746755C2 |
| IMPROVED SYNTHETIC T-CELL RECEPTOR AND ANTIGEN RECEPTOR | 2021 |
|
RU2820497C1 |
| T- CELLS WITH COSTIMULATING CHIMERIC ANTIGEN RECEPTOR TARGETING IL13Rα2 | 2015 |
|
RU2749922C2 |
| MUC16-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND THEIR USE | 2019 |
|
RU2795198C2 |
| CHIMERIC ANTIGEN RECEPTORS TO MYELOMA KAPPA ANTIGEN AND VERSIONS OF THEIR APPLICATION | 2016 |
|
RU2743188C2 |
